WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H561227
CAS#: 59813-89-7
Description: BIR2 is a balloon inducing reagent. BIR2 triggers a spontaneous self-organizing program that leads to the formation of a 3-D balloon-shaped structure during hESC differentiation.
Hodoodo Cat#: H561227
Name: BIR2
CAS#: 59813-89-7
Chemical Formula: C9H10N2S2
Exact Mass: 210.03
Molecular Weight: 210.310
Elemental Analysis: C, 51.40; H, 4.79; N, 13.32; S, 30.49
Synonym: BIR2; BIR-2; BIR 2; Balloon inducing reagent-2; Balloon inducing reagent 2
IUPAC/Chemical Name: 2-Ethylsulfanyl-benzothiazol-6-ylamine
InChi Key: TUMCWFMHZOUPDA-UHFFFAOYSA-N
InChi Code: InChI=1S/C9H10N2S2/c1-2-12-9-11-7-4-3-6(10)5-8(7)13-9/h3-5H,2,10H2,1H3
SMILES Code: NC1=CC=C2N=C(SCC)SC2=C1
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >2 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 210.31 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Geng Y, Feng B. A small molecule-based strategy for endothelial differentiation and three-dimensional morphogenesis from human embryonic stem cells. Heliyon. 2016;2(7):e00133. doi:10.1016/j.heliyon.2016.e00133.